Analysis
Unconventional AI, a Mountain View, California hardware startup that launched less than a year ago with a $4.5 billion valuation, is buying Israeli chip startup NeuReality in a cash-and-stock deal, 963 Jack FM reported on October 26, 2026, carrying a Reuters wire report. The purchase price wasn't disclosed. About 40 NeuReality employees will join Unconventional AI, which plans to keep a presence in Israel.
Why Unconventional AI is buying, not building
- Unconventional AI is led by Naveen Rao, a repeat chip-industry founder with two prior exits to his name:
- Nervana Systems -- sold to Intel for more than $400 million.
- MosaicML -- sold to Databricks for $1.3 billion.
“At the time of that raise, the company expected three years of R&D and five years to ship a product.”
His new venture raised $475 million in December on a bet that AI chips can get roughly 1,000 times more energy-efficient by borrowing "dynamical systems" principles from biological computing -- simple elements following simple rules rather than step-by-step programmed logic. At the time of that raise, the company expected three years of R&D and five years to ship a product. Rao said, per the wire report carried by 963 Jack FM, that progress has beaten those projections, after the company used AI tools to build a first test chip and nearly finish a second: "Things have gone a lot faster than anticipated... we've got to build up the production bones."
NeuReality's background
NeuReality was founded in 2019 by Moshe Tanach, a Marvell and Intel veteran, along with Tzvika Shmueli and Yossi Kasus. The company had already developed several AI inference chips before the acquisition, and Rao served on its board -- giving Unconventional AI an inside view of the team before buying it outright.
Competitive landscape
Unconventional AI's energy-efficiency pitch puts it in competition with inference-focused chip startups like Groq, Cerebras, SambaNova, and d-Matrix, all of which argue that today's GPU-centric approach wastes power on workloads that don't need full floating-point precision. Backers including Andreessen Horowitz, Sequoia Capital, and Jeff Bezos have bet that Rao's biological-systems approach gets there faster than rivals iterating on conventional chip architectures.
What the acquisition misses
However, an undisclosed price means outside investors can't yet tell whether this was a distressed sale for NeuReality -- which hadn't announced new funding recently -- or a fair-value deal for a team Rao already knew well from his board seat. Buying an engineering team to accelerate "production bones," as Rao put it, is also a tacit admission that the research phase ran ahead of Unconventional AI's own ability to productize it on the original five-year timeline.
What to watch
Whether Unconventional AI ships its second test chip on the accelerated timeline Rao described, and whether NeuReality's existing inference-chip customers stay through the transition.